Loading provider…
Loading provider…
Hematology & Oncology Physician in Albuquerque, NM
NPI: 1396035556Primary Practice Location
UNM HOSPITAL
2211 Lomas Blvd Ne, Albuquerque, NM
Primary Employer
UNM Medical Group - 2211 Lomas
pathology.unm.edu
HQ Phone
Get MD Bernard's Phone Numberphone_androidMobile
Get MD Bernard's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNC State Medical License
NM State Medical License
TX State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 73 | 153 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 46 | 78 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 22 | 26 |
| 4 | 99443Physician telephone patient service, 21-30 minutes of medical discussion | 16 | 24 |
| 5 | 99205New patient office or other outpatient visit, typically 60 minutes | 13 | 13 |
The RPL/RPS gene signature of melanoma CTCs associates with brain metastasis.
Authors: Bowley, Tetiana Y, Lagutina, Irina V, Francis, Carol, Sivakumar, Sinduja, Selwyn, Reed G, Taylor, Erik, Guo, Yan, Fahy, Bridget N, Tawfik, Bernard, Marchetti, Dario
Journal: Cancer Res Commun
Publication Date: 2022-11-16
Lead Sponsor: ECOG-ACRIN Cancer Research Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Carboplatin, DRUG: Temozolomide, OTHER: Laboratory Biomarker Analysis, DRUG: Cisplatin, DRUG: Capecitabine, DRUG: Etoposide
Lead Sponsor: SWOG Cancer Research Network
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, OTHER: Quality-of-Life Assessment, BEHAVIORAL: Patient Navigation, OTHER: Educational Intervention
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, DRUG: Docetaxel, OTHER: Quality-of-Life Assessment, DRUG: Atezolizumab, DRUG: Paclitaxel, OTHER: Placebo Administration, PROCEDURE: Computed Tomography, BIOLOGICAL: Trastuzumab, PROCEDURE: Biopsy, PROCEDURE: Bone Scan, BIOLOGICAL: Pertuzumab